Back to Search
Start Over
Factors Associated With Dupilumab Response in Atopic Dermatitis: A Systematic Review and Meta-Analysis
- Source :
- The Journal of Allergy and Clinical Immunology: In Practice; November 2024, Vol. 12 Issue: 11 p3044-3056, 13p
- Publication Year :
- 2024
-
Abstract
- Dupilumab was approved for treating moderate to severe atopic dermatitis (AD). However, a notable subset of patients remains unresponsive and factors associated with dupilumab response remain limited.
Details
- Language :
- English
- ISSN :
- 22132198
- Volume :
- 12
- Issue :
- 11
- Database :
- Supplemental Index
- Journal :
- The Journal of Allergy and Clinical Immunology: In Practice
- Publication Type :
- Periodical
- Accession number :
- ejs67373228
- Full Text :
- https://doi.org/10.1016/j.jaip.2024.08.054